News

Julio Rosenstock, MD: Work on World’s First Once-Weekly Basal Insulin Featured on the New England Journal of Medicine Homepage

Julio Rosenstock, MD, has his work spotlighted as the feature article on the New England Journal of Medicine’s homepage. Serving as the lead investigator for Novo Nordisk’s ONWARDS 1 program, Dr. Rosenstock has made remarkable strides in exploring what could be the world’s first once-weekly basal insulin. “In ONWARDS 1, insulin icodec allowed people to … Read more

PI Focus: Building Relationships Through Clinical Trials in the United Kingdom

For the team at Velocity Clinical Research in the United Kingdom, clinical trials are first and foremost about building relationships.  “I’m really grateful to be involved in clinical trials, because it allows me to develop meaningful connections with people in a way that goes beyond the traditional and [usually] more formal doctor-patient relationship,” says Ahmed … Read more

Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites

Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, and Privia Health (Nasdaq: PRVA), a physician enablement company serving more than 3,700 providers and 4.4 million patients, today announced a partnership to open embedded clinical research sites within Privia’s practice network. The partnership is intended to establish integrated research sites within existing Privia Care … Read more

Velocity Investigators Active at the American Diabetes Association (ADA) 83rd Scientific Sessions

Julio Rosenstock, MD, and Juan Frias, MD, were featured prominently throughout the American Diabetes Association (ADA) 83rd Scientific Sessions. The prolific researchers also had findings simultaneously published in the New England Journal of Medicine and The Lancet. Dr. Rosenstock is the lead investigator for Novo Nordisk’s ONWARDS 1 program exploring the first investigational once-weekly insulin. … Read more

PI Focus: Velocity PI Leads Breakthrough Efforts to Combat Obesity, Diabetes

The Velocity Clinical Research team in Los Angeles, CA, is tackling two of the biggest health threats to Americans today: obesity and diabetes. Better still, they’re making tremendous progress against these conditions that exact a terrible toll on quality of life and longevity. Consider these sobering statistics from the Centers for Disease Control and Protection … Read more

Velocity PAC Insights: Communicating With Participants, Cutting No-Shows, and Improving Informed Consent

Velocity Clinical Research maintains a Participant Advisory Committee (PAC) — a diverse mix of current and past trial participants across the U.S. The PAC’s job? Providing participant input to fine-tune the clinical research process. In this piece, we dig into highlights from PAC’s recent meetings in March, April, and May 2023. We’ll cover three key … Read more

PI Focus: Luis De La Cruz, MD on Sleep Apnea

Luis De La Cruz, MD

In this ongoing series, Velocity puts the spotlight on innovative Principal Investigators (PIs) whose work is changing the medical landscape at the intersection of research and patient care.  Velocity Team Contributes to Potential Breakthrough Sleep Apnea Treatment Enjoying a good night’s sleep is vitally important both mentally and physically. Unfortunately, for many it’s a struggle … Read more

Paul Evans Named a Featured Speaker of the Cornell University Biotech and Pharmaceutical Summit

Paul Evans, PhD, President and Chief Executive Officer of Velocity, has been named a featured speaker of the Biotech and Pharmaceutical Management Summit through Cornell University. The summit at Cornell Tech will enable participants to engage with industry leaders and Cornell faculty in small panel discussions on topics such as the payer perspective, barriers and … Read more

Ride4DEI Promotes Stronger Clinical Trial Industry

Ride4DEI Promotes Stronger Clinical Trial Industry

CUMBERLAND, MD – It’s been smooth biking so far for the ACRP Ride4DEI team as they wrapped up day three yesterday (May 16) en route from Pittsburgh, PA to Washington, D.C. in an effort to raise money and awareness promoting diversity on all levels in clinical trials. But obstacles loom for the plucky bikers, says … Read more